SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-038547
Filing Date
2021-03-19
Accepted
2021-03-18 20:07:16
Documents
3
Period of Report
2021-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2110212d1_8k.htm 8-K 19809
2 EXHIBIT 99.1 tm2110212d1_ex99-1.htm EX-99.1 7374
3 GRAPHIC tm2110212d1_ex99-1img001.jpg GRAPHIC 11672
  Complete submission text file 0001104659-21-038547.txt   44765
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39788 | Film No.: 21756138
SIC: 2834 Pharmaceutical Preparations